Garlic oil
Based on 1 Customer Validation
Garlic oil is an orally effective anti-inflammatory, antioxidant, and anticancer agent. Garlic oil inhibits the activation of NF-κB, NFκB2 and NLRP3 inflammasome, and induces the expression of GSTA1, HO-1 and NQO-1. Garlic oil reduces the Bcl-2/Bax protein ratio and activates NNK-induced apoptosis (apoptosis) in lung tissues. Garlic oil attenuates NNK-induced apoptosis in MRC-5 cells and reduces excessive ROS production. Garlic oil alleviates pyroptosis (pyroptosis) and exerts a protective effect against acute lung injury in mice. Garlic oil inhibits lung tumorigenesis in mice and improves small intestinal motility in rats with type 2 diabetes. Garlic oil can be used in research related to acute lung injury, lung cancer, peptic ulcer, type 2 diabetes and hypertension.
For research use only. We do not sell to patients.
- CAS No.: 8000-78-0
-
Storage:
RT, sealed storage, away from moisture and light.
In solvent -80°C, 1 year , -20°C, 6 months
Biological Activity
Description
In Vitro
Garlic oil (1-4 μg/mL; 48 h) dose-dependently reverses the decrease in MRC-5 cell viability induced by NNK (HY-126477)[2].
Garlic oil (2 μg/mL; 48 h) significantly reduces NNK-induced apoptosis in MRC-5 cells[2].
Garlic oil (48 h) significantly reduces NNK-induced excessive ROS production in MRC-5 cells, reverses GSH depletion, protects cells against NNK-induced DNA strand breaks and loss of mitochondrial membrane potential, and reduces endoplasmic reticulum stress[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MRC-5 cells
-
Concentration:1 μg/mL, 2 μg/mL, 4 μg/mL
-
Incubation Time:48 h
-
Result:Had no significant effect on MRC-5 cell viability at 1 μg/mL or 2 μg/mL for 48 h.
Significantly decreased cell viability compared to the control at 4 μg/mL for 48 h.
Dose-dependently reversed NNK-induced cell viability loss at 1 μg/mL or 2 μg/mL for 48 h.
-
Cell Line:MRC-5 cells
-
Concentration:2 μg/mL
-
Incubation Time:48 h
-
Result:Reduced the NNK-induced apoptosis rate from 38.3% to 14.4% in MRC-5 cells.
In Vivo
Garlic oil (25-50 mg/kg; p.o.; daily; 18 weeks) dose-dependently inhibits NNK-induced lung tumorigenesis in A/J mice[2].
Garlic oil (5 mL/kg/day; oral administration; once daily for consecutive 2 weeks) improves intestinal motility, alleviates oxidative stress, reduces blood glucose levels and improves insulin resistance, reverses histological damage, and increases BMI and Lee index in female Wistar rats with experimental type 2 diabetes[4].
Garlic oil (5 mL/kg/day; p.o.; daily administration for 2 consecutive weeks) reduces intestinal contractility and motility index in healthy female Wistar rats, increases BMI, Lee index and waist circumference, enhances oxidative stress levels in the duodenum, and decreases GSH-Px activity in the jejunum, but exerts no effect on glycemic control[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male, 6-8 weeks old, LPS-induced acute lung injury model)[1]
-
Dosage:100 mg/kg
-
Administration:i.t.; single dose; 4 hours before LPS instillation
-
Result:Reduced LPS-induced lung injury scores, myeloperoxidase (MPO) activity in lung tissue, total cell counts and total protein levels in bronchoalveolar lavage fluid (BALF), and mRNA/protein levels of inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-18) in lung tissue and BALF.
Decreased LPS-induced activation of NF-κB (reduced p-p65/p65 ratio), expression of NLRP3 inflammasome components (NLRP3, ASC, cleaved caspase-1), and levels of pyroptosis markers (cleaved GSDMD-N, cleaved GSDME-N) in lung tissue, lowering the pyroptosis rate of primary alveolar epithelial cells from 9.06% to 5.15%.
Increased lung tissue expression of H2S-producing enzymes (CBS, CSE) and H2S production levels.
Reversed all protective effects when H2S production was inhibited via IAM or AOAA + PAG.
-
Animal Model:A/J mice (5-8 weeks old, 5 male and 5 female per group, intraperitoneal injection of 100 mg/kg NNK to induce tumorigenesis)[2]
-
Dosage:25 mg/kg; 50 mg/kg
-
Administration:p.o.; daily; 18 weeks
-
Result:Significantly reduced lung tumor number compared to the NNK model group.
Significantly reduced lung tumor number compared to the NNK model group, with greater efficacy than the 25 mg/kg dose.
Reversed NNK-induced increases in Bcl-2 protein expression and decreases in Bax protein expression, reducing the Bcl-2/Bax ratio.
Increased protein expression of phase II drug-metabolizing enzymes HO-1, NQO1, and GSTA1 in lung tissue in a dose-dependent manner.
Increased mRNA expression of HO-1 and NQO1 in lung tissue.
-
Animal Model:Wistar rats (adult female, 150-180 g, experimentally induced type 2 diabetes mellitus)[4]
-
Dosage:5 mL/kg/day
-
Administration:p.o.; daily; 2 consecutive weeks
-
Result:Significantly increased average duration of contraction in duodenum, jejunum, and ileum.
Significantly elevated average force of contraction and motility index in duodenum, jejunum, and ileum, bringing duodenal values to levels insignificantly different from control rats.
Significantly lowered fasting blood glucose compared to untreated diabetic rats.
Significantly reduced HOMA-IR score compared to untreated diabetic rats, to levels insignificantly different from control rats.
Significantly reduced duodenal and ileal malondialdehyde (MDA) levels compared to untreated diabetic rats.
Significantly lowered jejunal CAT activity compared to untreated diabetic rats (reducing it to levels insignificantly different from controls), while duodenal CAT activity was unchanged.
Significantly decreased duodenal glutathione peroxidase (GSH-Px) activity compared to untreated diabetic rats (but unchanged compared to controls).
Significantly decreased jejunal GSH-Px activity compared to untreated diabetic rats (and unchanged in untreated diabetic rats compared to controls).
Significantly reduced ileal GSH-Px activity compared to untreated diabetic rats.
Significantly increased body mass index (BMI) compared to untreated diabetic rats.
Significantly increased Lee index compared to untreated diabetic rats.
Showed restored villi and muscle arrangement, reduced mononuclear cell infiltration, and myenteric nervous plexus with basophilic cytoplasm and normal vesicular nuclei in duodenum, jejunum, and ileum, compared to the distorted, inflamed tissue of untreated diabetic rats.
Waist circumference was insignificantly changed compared to untreated diabetic rats.
-
Animal Model:Wistar rats (adult female, 150-180 g, healthy)[4]
-
Dosage:5 mL/kg/day
-
Administration:p.o.; daily; 2 consecutive weeks
-
Result:Significantly lowered average force of contraction and motility index in duodenum, jejunum, and ileum compared to control rats.
No significant changes were observed in frequency of contraction or average duration of contraction across all small intestinal segments.
No significant changes were observed in fasting blood glucose, fasting insulin level, HOMA-IR score, or HbA1c compared to control rats.
Significantly elevated duodenal MDA level compared to control rats.
No significant changes were observed in jejunal or ileal MDA, or CAT activity in any small intestinal segment.
Significantly decreased jejunal GSH-Px activity compared to control rats, while duodenal and ileal GSH-Px activity was unchanged compared to control rats.
Significantly increased BMI, Lee index, and waist circumference compared to control rats.
Showed regular villi and crypts with basophilic cytoplasm, vesicular nuclei, and normal myenteric nervous plexus in duodenum and jejunum; ileum showed normal villi and crypts but with mononuclear cell infiltration.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 8000-78-0
-
Appearance Liquid (Density: 1.083 g/cm3)
-
Color Light yellow to yellow
-
SMILES
[Garlic oil]
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
RT, sealed storage, away from moisture and light
In solvent -80°C 1 year -20°C 6 months
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 5 mg/mL; Clear solution; Need ultrasonic
This protocol yields a clear solution of 5 mg/mL.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Inhalation Toxicity Study
Inhalation toxicity studies expose rodents to a controlled aerosol, vapor, gas, or smoke atmosphere and assess respiratory and systemic toxicity using exposure-atmosphere characterization, clinical observations, body and organ weights, bronchoalveolar lavage fluid, histopathology, blood chemistry, hematology, and, when included, molecular endpoints such as transcriptomics, proteomics, lipidomics, or tissue burden analysis. The primary biological readouts are airway irritation, pulmonary inflammation, cytotoxicity, altered surfactant or lipid homeostasis, impaired particle clearance, and tissue remodeling, reflected by BALF cell differentials, BALF protein, LDH, phosphatase activities, cytokines, lung weight, microscopic respiratory-tract lesions, and retained lung burden.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
-
Data Sheet (290 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Dilxat T, et al. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via HS generation. Aging. 2024 Apr 12;16(7):6521-6536. [Content Brief]
[2]. Zhang L, et al. Garlic oil blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis by inducing phase II drug-metabolizing enzymes. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2021 Nov;157:112581. [Content Brief]
[3]. Kuna L, et al. Pretreatment of Garlic Oil Extracts Hampers Epithelial Damage in Cell Culture Model of Peptic Ulcer Disease. Medicina (Kaunas, Lithuania). 2022 Jan 07;58(1):91. [Content Brief]
[4]. Saleh NKM, et al. Garlic oil improves small intestinal motility in experimentally induced type II diabetes mellitus in female Wistar rats. PloS one. 2024;19(4):e0301621. [Content Brief]
[5]. Tain YL, et al. Perinatal Garlic Oil Supplementation Averts Rat Offspring Hypertension Programmed by Maternal Chronic Kidney Disease. Nutrients. 2022 Nov 02;14(21):4624. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)